What screening can and cannot do

Screening tests people without symptoms, aiming to find cancer early — or, for some cancers, to find and remove precancerous changes before cancer develops. Colorectal and cervical screening do the latter, which is why they are particularly effective.

Screening is not universally beneficial. For a test to be recommended, the cancer must be common enough, the test accurate enough, and finding it early must actually change outcomes. Many cancers do not meet those conditions, which is why there is no recommended screening for pancreatic, ovarian, or thyroid cancer in average-risk adults.

  • False positives — abnormal results that turn out not to be cancer, causing anxiety and further testing.
  • False negatives — missed cancers, which is why new symptoms always warrant evaluation.
  • Overdiagnosis — finding cancers that would never have caused harm, leading to treatment with real side effects.
  • Procedure risks — small but real for invasive follow-up such as biopsy or colonoscopy.

The screenings with the strongest evidence

These have clear recommendations from bodies such as the USPSTF and American Cancer Society, with details varying slightly between them.

  • Colorectal cancer — from age 45 for average risk. Options include colonoscopy every ten years, stool-based tests annually or every one to three years depending on type, and CT colonography. Any positive stool test needs a colonoscopy to complete the screening.
  • Cervical cancer — from age 21. Cytology every three years, or HPV-based testing at longer intervals in the appropriate age range, typically to around 65.
  • Breast cancer — mammography beginning in the forties, with expert bodies continuing to discuss exact intervals and stopping age.
  • Lung cancer — annual low-dose CT for adults in the eligible age range with a significant smoking history who currently smoke or quit within the past 15 years.

All of these have age ranges and intervals that depend on individual risk, so treat this as orientation rather than a personal schedule.

Shared decisions and tests without routine recommendations

Some screening is offered as a discussion rather than a recommendation, because benefits and harms are closely balanced.

Prostate cancer — PSA testing is framed as an individual decision, typically from around 55 to 69 and earlier for Black men and those with a family history. The benefit is a modest reduction in prostate cancer deaths; the harms include false positives, biopsy complications, and overdiagnosis leading to treatment side effects.

Skin cancer — routine whole-body screening in average-risk adults is not currently recommended by USPSTF, though people with many moles, prior skin cancer, or high sun exposure may be monitored. Report new or changing lesions regardless.

Not recommended for average-risk adults: ovarian, pancreatic, testicular, and thyroid cancer screening, and whole-body imaging sold direct to consumers, which generates incidental findings without demonstrated benefit. Multi-cancer early detection blood tests are an active research area; they are not yet part of standard recommendations and their effect on outcomes is still being studied.

When family history changes the plan

A meaningful family history can move screening earlier, make it more frequent, or add tests entirely. It is one of the most useful things you can bring to an appointment, and one of the most commonly incomplete.

  • Record which relative, which cancer, and the age at diagnosis.
  • Include both sides of the family; risk is not carried only by the same-sex line.
  • Breast and ovarian cancer clustering, or diagnosis at a young age, may prompt genetic counselling.
  • Colorectal cancer or advanced polyps in a first-degree relative usually means starting earlier than 45 and screening more often.
  • Multiple cancers in one person, or several close relatives affected, are patterns worth flagging.

Genetic counselling is a discussion first, not a test. It clarifies whether testing would change anything before anyone is tested.

Symptoms are not screening

An important distinction: screening applies to people without symptoms. If you have symptoms, you need evaluation regardless of when you were last screened and regardless of a normal result.

  • Unexplained weight loss.
  • Blood in stool or urine, or bleeding between periods or after menopause.
  • A new lump anywhere, or a change in an existing one.
  • A cough or hoarseness lasting more than three weeks.
  • A change in bowel habit lasting more than a few weeks.
  • A sore or skin lesion that does not heal, or a mole that changes.
  • Difficulty swallowing, or persistent unexplained pain.

Most of these turn out to have non-cancer explanations. That is a reason to get them checked promptly, not a reason to wait.